進行がん患者の早期緩和ケア:クラスターランダム化制御試験
Camilla Zimmermann1, Nadia Swami2, Monika Krzyzanowska3
1Division of Medical Oncology and Haematology, Department of Medicine, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Psychosocial Oncology and Palliative Care, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Campbell Family Cancer Research Institute, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Lancet (London, England)
|February 25, 2014
まとめ
早期の緩和ケアにより,進行がん患者の生活の質と満足度が向上しました. 3ヵ月目には有意ではないが,4ヵ月目には利益が見られ,統合を支えた.
科学分野:
- 腫瘍学 腫瘍学
- 緩和ケアとは,緩和ケアです.
- 生活の質の研究 生活の質の研究
背景:
- 進行がんの患者は,生活の質の低下を経験し,特に終末期に近づいている.
- 緩和医療の早期統合は,これらの生活の質の低下を緩和することを目的としています.
研究 の 目的:
- 進行がん患者の生活の質に対する早期の緩和ケアコンサルティングの影響を評価する.
- 症状の重症度,ケアに対する満足度,医療との相互作用に関する問題を評価する.
主な方法:
- 24の腫瘍学診療所を含むクラスターランダム化試験で,緩和ケアチームと標準ケアを比較した.
- 進行がん (ECOG 0-2,予後6~24ヶ月) の患者は,4ヶ月間毎月評価されました.
- 生活の質 (FACIT-Sp, QUAL-E),症状 (ESAS),満足度 (FAMCARE-P16) および医療相互作用 (CARES-MIS) は,主および二次的アウトカムでした.
主要な成果:
- 4ヶ月で,早期の緩和ケアグループは,終末期の生活の質 (QUAL-E) と満足度 (FAMCARE-P16) で有意な改善を好みました.
- プライマリエンドポイント (3ヶ月後のFACIT-Sp) は非有意であったが,トレンドは介入グループに好意的であった.
- 症状の重症度 (ESAS) と医学的相互作用の問題 (CARES-MIS) は3ヶ月で有意な違いを示さなかったが,4ヶ月で改善した.
結論:
- 早期の緩和医療は,進行がん患者にとって有望な利点を示し,全体的な幸福感とケア満足度を高めています.
- 非有意なプライマリエンドポイントにもかかわらず,この研究は,病気の軌道の初期に緩和ケアサービスを統合することを支持しています.
関連する概念動画
Continuing Care
1.8K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.8K
Cancer Survival Analysis
863
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
863
Nursing Ethical Principles II
2.4K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
2.4K
Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
